← Back to Clinical Trials
Recruiting NCT04201600

NCT04201600 Glucose Variability and Cognition in Prediabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04201600
Status Recruiting
Phase
Sponsor University of Maryland, Baltimore
Condition Glucose Metabolism Disorders (Including Diabetes Mellitus)
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2022-03-01
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Continuous Glucose Monitoring System (CGMS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2022-03-01 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.

Eligibility Criteria

Inclusion Criteria: * Aged 50 years and older * At least 8th grade education Exclusion Criteria: * Diagnosed type 1 or type 2 diabetes * Current use of mediation for diabetes (oral hypoglycemic agents, insulin), or with diabetic properties (e.g., steroids) * Chronic disorders (cardiovascular disease, peripheral vascular disease, stroke, transient ischemic attack, chronic kidney disease, past year cancer) * Neurological disorders (e.g., Parkinson's, epilepsy, multiple sclerosis) * History of dementia or suspected dementia * Known HIV * Serious mental illness, psychosis, or use of psychotropic medication * Heavy alcohol use

Contact & Investigator

Central Contact

Kathleen Simpson

✉ Kathleen.Simpson@va.gov

📞 4106057179

Principal Investigator

Tasneem Khambaty, PhD

PRINCIPAL INVESTIGATOR

University of Maryland, Baltimore County

Frequently Asked Questions

Who can join the NCT04201600 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Glucose Metabolism Disorders (Including Diabetes Mellitus). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04201600 currently recruiting?

Yes, NCT04201600 is actively recruiting participants. Contact the research team at Kathleen.Simpson@va.gov for enrollment information.

Where is the NCT04201600 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT04201600 clinical trial?

NCT04201600 is sponsored by University of Maryland, Baltimore. The principal investigator is Tasneem Khambaty, PhD at University of Maryland, Baltimore County. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology